Submitting/Presenting Author

Erica Wee, Children's Mercy HospitalFollow

Presenter Status

Fellow

Abstract Type

Research

Primary Mentor

Kelsee Halpin, MD, MPH

Start Date

6-5-2022 12:00 PM

End Date

6-5-2022 12:15 PM

Presentation Type

Oral Presentation

Description

Watch recording of live presentation.

Background The prevalence of type 2 diabetes mellitus (T2D) in youth has increased significantly over the past decades secondary to the increased prevalence of obesity. Epidemiologic data estimates that the incidence of youth-onset T2D increased 5% per year between 2002 and 2012. Recent studies have shown that childhood obesity increased with the COVID-19 pandemic. However, if this resulted in increased incidence of T2D has not been well-reported.

Objectives: This study seeks to evaluate new-onset T2D in youth during the COVID-19 pandemic (March 2020 to February 2021). We examined the frequency of new-onset T2D and proportion of new-onset T2D presenting in diabetic ketoacidosis (DKA) and/or hyperglycemic hyperosmolar state (HHS) during the COVID-19 pandemic compared to the prior 2 years (March 2018 to February 2019 and March 2019 to February 2020).

Study Design: A retrospective chart review of new-onset T2D in patients < 21 years was conducted between March 2018 and February 2021. Demographic and clinical data including frequency of DKA/HHS were collected. DKA defined as bicarbonate < 16 mmol/L. HHS defined as serum osmolality ≥ 330 mOsm/kg and serum glucose >600 mg/dL. Patients with any positive diabetes autoantibody were excluded.

Results: A total of 163 patients (mean [SD] 14.3 [2.3] years, 53% females, 41% Black, 27% Hispanic) were evaluated. Sixty-nine patients were diagnosed with T2D during the pandemic year which was an increase of 47% compared to the mean (n=47) diagnoses per year pre-pandemic. Two of 15 tested were COVID positive. There was no difference in BMI (p=0.440), HbA1c (p=0.584), nor initial glucose (p= 0.184) between pandemic and pre-pandemic groups. There was significantly more newly diagnosed T2D, about 1 in 4, needing inpatient admission at presentation during the pandemic vs. 1 in 20 pre-pandemic (p= 0.001). There was twice the number of patients (n=8) presenting with DKA, of which 3 had both DKA and HHS. These 3 patients with HHS all had initial serum glucose of > 1000 mg/dL. There were no patients who presented with HHS at T2D diagnosis pre-pandemic.

Conclusions: In conclusion, we noted increased incidence of T2D during the pandemic, which was more than anticipated based on epidemiologic data. We also noted a significant increase in the severity of presentation at T2D diagnosis with twice as many DKA/HHS diagnoses and more hospitalizations. Further studies are needed to determine if this increase in incidence and severity will persist over an extended period.

MeSH Keywords

type 2 diabetes; incidence; COVID-19

Share

COinS
 
May 6th, 12:00 PM May 6th, 12:15 PM

Type 2 Diabetes Mellitus During the COVID-19 Pandemic

Watch recording of live presentation.

Background The prevalence of type 2 diabetes mellitus (T2D) in youth has increased significantly over the past decades secondary to the increased prevalence of obesity. Epidemiologic data estimates that the incidence of youth-onset T2D increased 5% per year between 2002 and 2012. Recent studies have shown that childhood obesity increased with the COVID-19 pandemic. However, if this resulted in increased incidence of T2D has not been well-reported.

Objectives: This study seeks to evaluate new-onset T2D in youth during the COVID-19 pandemic (March 2020 to February 2021). We examined the frequency of new-onset T2D and proportion of new-onset T2D presenting in diabetic ketoacidosis (DKA) and/or hyperglycemic hyperosmolar state (HHS) during the COVID-19 pandemic compared to the prior 2 years (March 2018 to February 2019 and March 2019 to February 2020).

Study Design: A retrospective chart review of new-onset T2D in patients < 21 years was conducted between March 2018 and February 2021. Demographic and clinical data including frequency of DKA/HHS were collected. DKA defined as bicarbonate < 16 mmol/L. HHS defined as serum osmolality ≥ 330 mOsm/kg and serum glucose >600 mg/dL. Patients with any positive diabetes autoantibody were excluded.

Results: A total of 163 patients (mean [SD] 14.3 [2.3] years, 53% females, 41% Black, 27% Hispanic) were evaluated. Sixty-nine patients were diagnosed with T2D during the pandemic year which was an increase of 47% compared to the mean (n=47) diagnoses per year pre-pandemic. Two of 15 tested were COVID positive. There was no difference in BMI (p=0.440), HbA1c (p=0.584), nor initial glucose (p= 0.184) between pandemic and pre-pandemic groups. There was significantly more newly diagnosed T2D, about 1 in 4, needing inpatient admission at presentation during the pandemic vs. 1 in 20 pre-pandemic (p= 0.001). There was twice the number of patients (n=8) presenting with DKA, of which 3 had both DKA and HHS. These 3 patients with HHS all had initial serum glucose of > 1000 mg/dL. There were no patients who presented with HHS at T2D diagnosis pre-pandemic.

Conclusions: In conclusion, we noted increased incidence of T2D during the pandemic, which was more than anticipated based on epidemiologic data. We also noted a significant increase in the severity of presentation at T2D diagnosis with twice as many DKA/HHS diagnoses and more hospitalizations. Further studies are needed to determine if this increase in incidence and severity will persist over an extended period.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.